Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_assertion type Assertion NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_head.
- NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_assertion description "[MET, a receptor tyrosine kinase for hepatocyte growth factor, is associated with tumor progression and acquired resistance to epidermal growth factor tyrosine kinase inhibitors (EGFR-TKI).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_provenance.
- NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_assertion evidence source_evidence_literature NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_provenance.
- NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_assertion SIO_000772 21733594 NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_provenance.
- NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_assertion wasDerivedFrom befree-2016 NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_provenance.
- NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_assertion wasGeneratedBy ECO_0000203 NP907515.RAeuaPWSHMOD4c-WjBcYX31rM6MS_tlBD25N_OLGlaI7Y130_provenance.